Back
ACADIA Pharmaceuticals, Inc. Vs. Elevance Health, Inc. Industry Stock Comparison
Buy
56
ACAD
ACADIA Pharmaceuticals, Inc.
Last Price:
$26.84
Seasonality Move:
12.49%
Buy
63
ELV
Elevance Health, Inc.
Last Price:
$352.04
Seasonality Move:
5.15%
Buy
56
ACADIA Pharmaceuticals, Inc. (ACAD)
is a Buy
Is ACADIA Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current ACADIA Pharmaceuticals, Inc. [ACAD] share price is $27.26. The Score for ACAD is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
ACAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Elevance Health, Inc. (ELV)
is a Buy
Is Elevance Health, Inc. a Buy, Sell or Hold?
-
The current Elevance Health, Inc. [ELV] share price is $360.67. The Score for ELV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
ELV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals, Inc.'s stock price today?
-
The ACADIA Pharmaceuticals, Inc. share price today is $27.26The current trend is moderately bullish and ACAD is experiencing slight buying pressure.
ELV Stock Price Chart
What is Elevance Health, Inc.'s stock price today?
-
The Elevance Health, Inc. share price today is $360.67The current trend is moderately bullish and ELV is experiencing slight buying pressure.
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 70.19 | Buy |
| Chaikin Money Flow: | 527066 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.46 - 26.54) | Buy |
| Bollinger Bands (100): | (21.85 - 25.57) | Buy |
ELV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.63 | Buy |
| Relative Strength Index (14 RSI): | 69.39 | Buy |
| Chaikin Money Flow: | 457504 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (318.21 - 344.83) | Buy |
| Bollinger Bands (100): | (300.39 - 342.87) | Buy |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.94 | Buy |
| 20-day SMA: | 25.36 | Buy |
| 50-day SMA: | 23.31 | Buy |
| 200-day SMA: | 21.31 | Buy |
| 8-day EMA: | 26.72 | Buy |
| 20-day EMA: | 25.63 | Buy |
| 50-day EMA: | 24.28 | Buy |
| 200-day EMA: | 21.99 | Buy |
ELV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 343.21 | Buy |
| 20-day SMA: | 334.36 | Buy |
| 50-day SMA: | 335.85 | Buy |
| 200-day SMA: | 357.41 | Buy |
| 8-day EMA: | 347.34 | Buy |
| 20-day EMA: | 338.21 | Buy |
| 50-day EMA: | 333 | Buy |
| 200-day EMA: | 354.95 | Buy |
ACADIA Pharmaceuticals, Inc. Earnings Growth & ACAD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.00 per share.
Elevance Health, Inc. Earnings Growth & ELV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.97 per share, and a decrease next year of $2.94 per share.
ACADIA Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Elevance Health, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||